Sex and gender: modifiers of health, disease, and medicine F Mauvais-Jarvis, NB Merz, PJ Barnes, RD Brinton, JJ Carrero, ... The Lancet 396 (10250), 565-582, 2020 | 1432 | 2020 |
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis G Targher, CD Byrne, A Lonardo, G Zoppini, C Barbui Journal of hepatology 65 (3), 589-600, 2016 | 1334 | 2016 |
Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome A Lonardo, S Ballestri, G Marchesini, P Angulo, P Loria Digestive and Liver disease 47 (3), 181-190, 2015 | 796 | 2015 |
Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps A Lonardo, F Nascimbeni, S Ballestri, DL Fairweather, S Win, TA Than, ... Hepatology 70 (4), 1457-1469, 2019 | 751 | 2019 |
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and … S Ballestri, S Zona, G Targher, D Romagnoli, E Baldelli, F Nascimbeni, ... Journal of gastroenterology and hepatology 31 (5), 936-944, 2016 | 739 | 2016 |
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes M Ricchi, MR Odoardi, L Carulli, C Anzivino, S Ballestri, A Pinetti, ... Journal of gastroenterology and hepatology 24 (5), 830-840, 2009 | 717 | 2009 |
Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? A Lonardo, F Nascimbeni, A Mantovani, G Targher Journal of hepatology 68 (2), 335-352, 2018 | 681 | 2018 |
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease A Lonardo, LE Adinolfi, P Loria, N Carulli, G Ruggiero, CP Day Gastroenterology 126 (2), 586-597, 2004 | 624 | 2004 |
Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups A Lonardo, S Bellentani, CK Argo, S Ballestri, CD Byrne, SH Caldwell, ... Digestive and Liver Disease 47 (12), 997-1006, 2015 | 528 | 2015 |
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo, D Romagnoli, ... Advances in therapy 34, 1291-1326, 2017 | 525 | 2017 |
From NAFLD in clinical practice to answers from guidelines F Nascimbeni, R Pais, S Bellentani, CP Day, V Ratziu, P Loria, A Lonardo Journal of hepatology 59 (4), 859-871, 2013 | 493 | 2013 |
Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus G Targher, A Lonardo, CD Byrne Nature reviews endocrinology 14 (2), 99-114, 2018 | 389 | 2018 |
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease: A decalogue from the Italian Association for the Study of the Liver (AISF) Expert … P Loria, LE Adinolfi, S Bellentani, E Bugianesi, A Grieco, S Fargion, ... Digestive and Liver Disease 42 (4), 272-282, 2010 | 357 | 2010 |
Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease S Ballestri, A Lonardo, S Bonapace, CD Byrne, P Loria, G Targher World journal of gastroenterology: WJG 20 (7), 1724, 2014 | 346 | 2014 |
Nonalcoholic fatty liver disease and aging: epidemiology to management M Bertolotti, A Lonardo, C Mussi, E Baldelli, E Pellegrini, S Ballestri, ... World journal of gastroenterology: WJG 20 (39), 14185, 2014 | 335 | 2014 |
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis A Mantovani, G Zaza, CD Byrne, A Lonardo, G Zoppini, E Bonora, ... Metabolism 79, 64-76, 2018 | 320 | 2018 |
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions A Lonardo, F Nascimbeni, G Targher, M Bernardi, F Bonino, E Bugianesi, ... Digestive and Liver Disease 49 (5), 471-483, 2017 | 316 | 2017 |
Non-alcoholic fatty liver disease and risk of cardiovascular disease A Lonardo, S Sookoian, CJ Pirola, G Targher Metabolism 65 (8), 1136-1150, 2016 | 272 | 2016 |
Liver and diabetes. A vicious circle P Loria, A Lonardo, F Anania Hepatology research 43 (1), 51-64, 2013 | 256 | 2013 |
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis LE Adinolfi, L Restivo, R Zampino, B Guerrera, A Lonardo, L Ruggiero, ... Atherosclerosis 221 (2), 496-502, 2012 | 255 | 2012 |